EML4-ALK: Honing In on a New Target in Non-Small-Cell Lung Cancer

被引：249

作者：

Horn, Leora ^{[1
]}

Pao, William ^{[1
]}

机构：

[1] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 26期

关键词：

GROWTH-FACTOR RECEPTOR; ACTIVATING MUTATIONS; FUSION GENE; ALK KINASE; KRAS MUTATIONS; NEVER SMOKERS; PHASE-III; NPM-ALK; GEFITINIB; IDENTIFICATION;

D O I：

10.1200/JCO.2009.23.6661

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：4232 / 4235

页数：4

共 50 条

[11] EML4-ALK Fusion Gene in Korean Non-Small Cell Lung Cancer
Jin, Guang
Jeon, Hyo-Sung
Lee, Eung Bae
Kang, Hyo-Gyoung
Yoo, Seung Soo
Lee, Shin Yup
Lee, Jae Hee
Cha, Sung Ick
Park, Tae In
Kim, Chang Ho
Jheon, Sang Hoon
Park, Jae Yong
JOURNAL OF KOREAN MEDICAL SCIENCE, 2012, 27 (02) : 228 - 230
[12] Analysis of EML4-ALK rearrangement in non-small cell lung cancer in Argentina
Verzura, Maria
Batagelj, Emilio
Bagnes, Claudia
Martin, Claudio
Enrico, Diego
Richardet, Eduardo
De la Iglesia, Paola
ANNALS OF DIAGNOSTIC PATHOLOGY, 2018, 34 : 77 - 81
[13] Targeting EML4-ALK driven non-small cell lung cancer (NSCLC)
Moran, Teresa
Quiroga, Vanesa
Llanos Gil, Maria de Los
Vila, Laia
Pardo, Nuria
Carcereny, Enric
Capdevila, Laia
Munoz-Marmol, Ana M.
Rosell, Rafael
TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (02) : 128 - 141
[14] EGFR and EML4-ALK Updated Therapies in Non-Small Cell Lung Cancer
de Mello, Ramon Andrade
Liu, Davi J. J.
Aguiar, Pedro N., Jr.
Tadokoro, Hakaru
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2016, 11 (04) : 393 - 400
[15] Comparison of small biopsy specimens and surgical specimens for the detection of EGFR mutations and EML4-ALK in non-small-cell lung cancer
Xiao, DeSheng
Lu, Can
Zhu, Wei
He, QiuYan
Li, Yong
Fu, ChunYan
Zhou, JianHua
Liu, Shuang
Tao, YongGuang
ONCOTARGET, 2016, 7 (37) : 59049 - 59057
[16] Preselection Based on Clinical Characteristics in German Non-Small-Cell Lung Cancer Patients Screened for EML4-ALK Translocation
Tufman, Amanda Laura Helen
Edelmann, Martin
Gamarra, Fernando
Reu, Simone
Borgmeier, Astrid
Schroedl, Kathrin
Zauber, Regine
Mueller-Lisse, Ullrich
Huber, Rudolf Maria
JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (01) : 109 - 113
[17] The prevalence of EML4-ALK variants in patients with non-small-cell lung cancer: a systematic review and meta-analysis
He, Yuan
Sun, Li-Yue
Gong, Rui
Liu, Qing
Long, Ya-Kang
Liu, Fang
Wang, Fang
BIOMARKERS IN MEDICINE, 2019, 13 (12) : 1035 - 1045
[18] The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement
Bilgin, Burak
Sendur, Mehmet Ali Nahit
Yucel, Sebnem
Hizal, Mutlu
Guner, Gurkan
Akyurek, Nalan
Erol, Cihan
Akinci, Muhammed Bulent
Dede, Didem Sener
Yalcin, Bulent
Kilickap, Sadettin
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (09) : 2637 - 2643
[19] EML4-ALK Rearrangement in Non-Small Cell Lung Cancer and Non-Tumor Lung Tissues
Martelli, Maria Paola
Sozzi, Gabriella
Hernandez, Luis
Pettirossi, Valentina
Navarro, Alba
Conte, Davide
Gasparini, Patrizia
Perrone, Federica
Modena, Piergiorgio
Pastorino, Ugo
Carbone, Antonino
Fabbri, Alessandra
Sidoni, Angelo
Nakamura, Shigeo
Gambacorta, Marcello
Luis Fernandez, Pedro
Ramirez, Jose
Chan, John K. C.
Grigioni, Walter Franco
Campo, Elias
Pileri, Stefano A.
Falini, Brunangelo
AMERICAN JOURNAL OF PATHOLOGY, 2009, 174 (02): : 661 - 670
[20] The effect of EML4-ALK break-apart ratio on crizotinib outcomes in non-small cell lung cancer harboring EML4-ALK rearrangement
Burak Bilgin
Mehmet Ali Nahit Şendur
Şebnem Yücel
Mutlu Hizal
Gürkan Güner
Nalan Akyürek
Cihan Erol
Muhammed Bülent Akıncı
Didem Şener Dede
Bülent Yalçın
Sadettin Kılıçkap
Journal of Cancer Research and Clinical Oncology, 2021, 147 : 2637 - 2643

← 1 2 3 4 5 →